Original language | English (US) |
---|---|
Pages (from-to) | E558-E561 |
Journal | Haematologica |
Volume | 104 |
Issue number | 12 |
DOIs | |
State | Published - 2019 |
ASJC Scopus subject areas
- Hematology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Haematologica, Vol. 104, No. 12, 2019, p. E558-E561.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses
AU - Cascione, Luciano
AU - Rinaldi, Andrea
AU - Bruscaggin, Alessio
AU - Tarantelli, Chiara
AU - Arribas, Alberto J.
AU - Kwee, Ivo
AU - Pecciarini, Lorenza
AU - Mensah, Afua A.
AU - Spina, Valeria
AU - Chung, Elaine Y.L.
AU - di Bergamo, Lodovico Terzi
AU - Dirnhofer, Stephan
AU - Tzankov, Alexandar
AU - Miranda, Roberto N.
AU - Young, Ken H.
AU - Traverse-Glehen, Alexandra
AU - Gaidano, Gianluca
AU - Swerdlow, Steven H.
AU - Gascoyne, Randy
AU - Rabadan, Raul
AU - Ponzoni, Maurilio
AU - Bhagat, Govind
AU - Rossi, Davide
AU - Zucca, Emanuele
AU - Bertoni, Francesco
N1 - Funding Information: 1Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland; 2Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland; 3Dalle Molle Institute for Artificial Intelligence (IDSIA), Manno, Switzerland; 4San Raffaele Scientific Institute, Milan, Italy; 5Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland; 6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 7Anatomie-pathologique, Hospices Civils de Lyon Centre, Lyon, France; 8Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; 9Division of Hematopathology, UPMC Presbyterian, Pittsburgh, PA, USA; 10British Columbia Cancer Agency, Vancouver, BC, Canada; 11Department of Systems Biology, Department of Biomedical Informatics, Columbia University College of Physicians & Surgeons, New York, NY, USA; 12Department of Pathology and Cell Biology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA and 13Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Funding: the authors would like to thank the financial support from the Nelia et Amadeo Barletta Foundation (Lausanne, Switzerland), the Oncosuisse (grant OCS-02034-02-2007), the Helmut Horten Foundation (to FB), the Special Program Molecular Clinical Oncology 5 x 1000 No. 10007, Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy (to GG), and the Cancer Center Support Grant - P30CA013696 (to GB). Correspondence: FRANCESCO BERTONI frbertoni@mac.com doi:10.3324/haematol.2018.214957 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
PY - 2019
Y1 - 2019
UR - http://www.scopus.com/inward/record.url?scp=85070884602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070884602&partnerID=8YFLogxK
U2 - 10.3324/haematol.2018.214957
DO - 10.3324/haematol.2018.214957
M3 - Letter
C2 - 31018978
AN - SCOPUS:85070884602
SN - 0390-6078
VL - 104
SP - E558-E561
JO - Haematologica
JF - Haematologica
IS - 12
ER -